MedicarePartD.guide

A non-government resource built from CMS public data

TASCENSO ODT .5 mg Tablet, Orally Disintegrating

Also known as Fingolimod Lauryl Sulfate. Coverage in New Jersey (CMS PDP Region 04).

Not on any stand-alone Part D formulary in New Jersey

None of the 12 stand-alone Part D (PDP) plans in CMS PDP Region 04 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

See coverage in all 39 regions →